FDA approves second Alzheimer’s drug that can slow onset of disease - The Guardian
- FDA approves second Alzheimer’s drug that can slow onset of disease The Guardian
- Approval of Newest Alzheimer's Drug Will Accelerate New Era of Treatment The Wall Street Journal
- FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease CNN
- Alzhiemer's drug Kisunla from Eli Lilly gains FDA approval USA TODAY
- FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s The New York Times